{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:01:12Z","timestamp":1784858472345,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Autonomous Region Key R&D Program Project","award":["Grant No.: 2022B03018-1"],"award-info":[{"award-number":["Grant No.: 2022B03018-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16209-6","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:06:32Z","timestamp":1779789992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV genotype distribution and cervical lesions in colposcopy-referred women in Western China: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lai","family":"Jiahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Siqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Keliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"16209_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11904-024-00727-5","volume":"22","author":"K Gopalkrishnan","year":"2025","unstructured":"Gopalkrishnan K, Karim R. Addressing global disparities in cervical cancer burden: A narrative review of emerging strategies. Curr HIV\/AIDS Rep. 2025;22(1):18. https:\/\/doi.org\/10.1007\/s11904-024-00727-5.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"15","key":"16209_CR2","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1097\/CM9.0000000000001441","volume":"134","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cai YB, James W, Zhou JL, Rezhake R, Zhang Q. Human papillomavirus distribution and cervical cancer epidemiological characteristics in rural population of Xinjiang, China. Chin Med J (Engl). 2021;134(15):1838\u201344. https:\/\/doi.org\/10.1097\/CM9.0000000000001441.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"16209_CR3","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2468-2667(21)00046-3","volume":"6","author":"M Bonjour","year":"2021","unstructured":"Bonjour M, Charvat H, Franco EL, Pi\u00f1eros M, Clifford GM, Bray F, et al. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: A birth cohort analysis. Lancet Public Health. 2021;6(7):e510\u201321. https:\/\/doi.org\/10.1016\/S2468-2667(21)00046-3.","journal-title":"Lancet Public Health"},{"key":"16209_CR4","doi-asserted-by":"publisher","first-page":"200258","DOI":"10.1016\/j.tvr.2023.200258","volume":"15","author":"CW Nelson","year":"2023","unstructured":"Nelson CW, Mirabello L. Human papillomavirus genomics: Understanding carcinogenicity. Tumour Virus Res. 2023;15:200258. https:\/\/doi.org\/10.1016\/j.tvr.2023.200258.","journal-title":"Tumour Virus Res"},{"issue":"8","key":"16209_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/v16081245","volume":"16","author":"IN Hampson","year":"2024","unstructured":"Hampson IN, Oliver AW. Update on effects of the prophylactic HPV vaccines on HPV type prevalence and cervical pathology. Viruses. 2024;16(8):1245. https:\/\/doi.org\/10.3390\/v16081245.","journal-title":"Viruses"},{"issue":"4","key":"16209_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.01.011","volume":"16","author":"AAA Oyouni","year":"2023","unstructured":"Oyouni AAA. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023;16(4):626\u201331. https:\/\/doi.org\/10.1016\/j.jiph.2023.01.011.","journal-title":"J Infect Public Health"},{"issue":"10","key":"16209_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.46234\/ccdcw2024.039","volume":"6","author":"K Sun","year":"2024","unstructured":"Sun K, Han B, Zeng H, Wang S, Li L, Chen R, et al. Incidence and mortality of cancers in female genital organs - China, 2022. China CDC Wkly. 2024;6(10):195\u2013202. https:\/\/doi.org\/10.46234\/ccdcw2024.039.","journal-title":"China CDC Wkly"},{"issue":"4","key":"16209_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/v12040380","volume":"12","author":"MA Oyervides-Mu\u00f1oz","year":"2020","unstructured":"Oyervides-Mu\u00f1oz MA, P\u00e9rez-Maya AA, S\u00e1nchez-Dom\u00ednguez CN, Berlanga-Garza A, Antonio-Macedo M, Vald\u00e9z-Chapa LD, et al. Multiple HPV infections and viral load association in persistent cervical lesions in Mexican women. Viruses. 2020;12(4):380. https:\/\/doi.org\/10.3390\/v12040380.","journal-title":"Viruses"},{"issue":"5","key":"16209_CR9","doi-asserted-by":"publisher","first-page":"e19244","DOI":"10.1371\/journal.pone.0019244","volume":"6","author":"SS Liu","year":"2011","unstructured":"Liu SS, Chan KYK, Leung RCY, Chan KKL, Tam KF, Luk MHM, et al. Prevalence and risk factors of human papillomavirus (HPV) infection in southern Chinese women \u2013 a population-based study. PLoS ONE. 2011;6(5):e19244. https:\/\/doi.org\/10.1371\/journal.pone.0019244.","journal-title":"PLoS ONE"},{"key":"16209_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2147\/IJGM.S312366","volume":"14","author":"J Xiang","year":"2021","unstructured":"Xiang J, Han L, Fan Y, Feng B, Wu H, Hu C, et al. Prevalence and genotype distribution of human papillomavirus among attendees at a sexually transmitted diseases clinic in urban Tianjin, China. Int J Gen Med. 2021;14:1983\u201390. https:\/\/doi.org\/10.2147\/IJGM.S312366.","journal-title":"Int J Gen Med"},{"issue":"9","key":"16209_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.20892\/j.issn.2095-3941.2024.0160","volume":"22","author":"S Ma","year":"2025","unstructured":"Ma S, Sun K, Han B, Zheng R, Wei W. Cervical cancer burden and trends in China, 2000\u20132020: Asia-pacific international comparisons and insights for elimination goals. Cancer Biol Med. 2025;22(9):1017\u201335. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0160.","journal-title":"Cancer Biol Med"},{"key":"16209_CR12","unstructured":"Xinhua News. Free HPV vaccination! A national commitment to protecting women\u2019s health. Xinhua Net. 2025. Available from: https:\/\/www1.xinhuanet.com\/politics\/20251030\/e139a081987a4c2586b12679b56bdd89\/c.html. [Cited 1 Dec 2025]."},{"key":"16209_CR13","unstructured":"Guangming Net. Strengthening defenses, lighting the hope for cervical cancer elimination. Guangming Net. 2025. Available from: https:\/\/health.gmw.cn\/2025-11\/04\/content_38390672.htm. [Cited 1 Dec 2025]."},{"key":"16209_CR14","doi-asserted-by":"publisher","first-page":"1455931","DOI":"10.3389\/fpubh.2024.1455931","volume":"12","author":"Y Kou","year":"2024","unstructured":"Kou Y, Tang X, Liang D, Xie C, Zeng J, Chen M, et al. HPV genotypes in invasive cervical cancer: Prevalence, risk attribution, and optimized vaccine strategies in western China. Front Public Health. 2024;12:1455931. https:\/\/doi.org\/10.3389\/fpubh.2024.1455931.","journal-title":"Front Public Health"},{"issue":"10","key":"16209_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2025.028","volume":"7","author":"M Zhang","year":"2025","unstructured":"Zhang M, Wang L, Zhang X, Li C, Zhao Z, Yu M, et al. Cervical cancer screening rates among Chinese women - China, 2023\u20132024. China CDC Wkly. 2025;7(10):321\u20136. https:\/\/doi.org\/10.46234\/ccdcw2025.028.","journal-title":"China CDC Wkly"},{"key":"16209_CR16","unstructured":"World Health Organization. Introduction. In: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV). 2nd ed. Geneva: World Health Organization. 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK604767\/. [Cited 1 Dec 2025]."},{"issue":"9","key":"16209_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.46234\/ccdcw2023.041","volume":"5","author":"D Gao","year":"2023","unstructured":"Gao D, Zhao G, Di J, Zhang X, Wang L. Knowledge of cervical cancer and HPV, and willingness to receive HPV vaccination among 20-45-year-old women - six provinces, China, 2018. China CDC Wkly. 2023;5(9):201\u20135. https:\/\/doi.org\/10.46234\/ccdcw2023.041.","journal-title":"China CDC Wkly"},{"issue":"3","key":"16209_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/LGT.0b013e3181d892e5","volume":"14","author":"A Balasubramanian","year":"2010","unstructured":"Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis. 2010;14(3):185\u201395. https:\/\/doi.org\/10.1097\/LGT.0b013e3181d892e5.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"16209_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17305\/bjbms.2016.1113","volume":"16","author":"M Niyazi","year":"2016","unstructured":"Niyazi M, Husaiyin S, Han L, Mamat H, Husaiyin K, Wang L. Prevalence of and risk factors for high-risk human papillomavirus infection: A population-based study from Hetian, Xinjiang, China. Bosn J Basic Med Sci. 2016;16(1):46\u201351. https:\/\/doi.org\/10.17305\/bjbms.2016.1113.","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"16209_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1186\/s12885-018-5076-0","volume":"18","author":"S Husaiyin","year":"2018","unstructured":"Husaiyin S, Han L, Wang L, Ma C, Ainiwaer Z, Rouzi N, et al. Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged\u2009>\u200930 years in Xinjiang. BMC Cancer. 2018;18(1):1162. https:\/\/doi.org\/10.1186\/s12885-018-5076-0.","journal-title":"BMC Cancer"},{"key":"16209_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13148-025-01498-7","volume":"17","author":"J de Waard","year":"2025","unstructured":"de Waard J, Bhattacharya A, de Boer MT, van Hemel BM, Esajas MD, Vermeulen KM, et al. Clinical validation of a three-marker methylation panel to detect CIN3\u2009+\u2009in vaginal self-samples in the dutch population-based screening programme. Clin Epigenetics. 2025;17:95. https:\/\/doi.org\/10.1186\/s13148-025-01498-7.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"16209_CR22","doi-asserted-by":"publisher","first-page":"e70238","DOI":"10.1002\/jmv.70238","volume":"97","author":"Z Lu","year":"2025","unstructured":"Lu Z, Dong B, Yao P, Huang Y, Fu L, Wang B, et al. Characteristics of human papillomavirus prevalence and infection patterns among women aged 35\u201365 in Fujian province, China: A nine-year retrospective observational study. J Med Virol. 2025;97(2):e70238. https:\/\/doi.org\/10.1002\/jmv.70238.","journal-title":"J Med Virol"},{"issue":"4","key":"16209_CR23","first-page":"437","volume":"24","author":"Chinese Society of Colposcopy and Cervical Pathology of China Healthy Birth Science Association, Chinese Society of Gynecologic Oncology of Chinese Medical Association, Gynecologic Oncology Committee of China Anti-Cancer Association, Obstetric and Gynecologic Health Branch of China International Exchange and Promotion Association for Medical and Healthcare, National Cervical Cancer Prevention and Treatment Collaborative Group of China Cancer Foundation","year":"2023","unstructured":"Chinese Society of Colposcopy and Cervical Pathology of China Healthy Birth Science Association, Chinese Society of Gynecologic Oncology of Chinese Medical Association, Gynecologic Oncology Committee of China Anti-Cancer Association, Obstetric and Gynecologic Health Branch of China International Exchange and Promotion Association for Medical and Healthcare, National Cervical Cancer Prevention and Treatment Collaborative Group of China Cancer Foundation. Chinese cervical cancer screening guidelines (Part 1). Chin J Clin Obstet Gynecol. 2023;24(4):437\u201342. Oncology Prevention and Control Committee of China Preventive Medicine Association.","journal-title":"Chin J Clin Obstet Gynecol"},{"issue":"1","key":"16209_CR24","first-page":"88","volume":"26","author":"Chinese Society of Colposcopy and Cervical Pathology of China Healthy Birth Science Association, Chinese Society of Gynecologic Oncology of Chinese Medical Association, Cervical Cancer Committee of China Anti-Cancer Association, Obstetric and Gynecologic Health Branch of China International Exchange and Promotion Association for Medical and Healthcare, National Cervical Cancer Prevention and Treatment Collaborative Group of China Cancer Foundation","year":"2025","unstructured":"Chinese Society of Colposcopy and Cervical Pathology of China Healthy Birth Science Association, Chinese Society of Gynecologic Oncology of Chinese Medical Association, Cervical Cancer Committee of China Anti-Cancer Association, Obstetric and Gynecologic Health Branch of China International Exchange and Promotion Association for Medical and Healthcare, National Cervical Cancer Prevention and Treatment Collaborative Group of China Cancer Foundation. Chinese cervical cancer screening guidelines (Part 2). Chin J Clin Obstet Gynecol. 2025;26(1):88\u201396. Oncology Prevention and Control Committee of China Preventive Medicine Association.","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"16209_CR25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1186\/s12885-025-13996-8","volume":"25","author":"Y Ren","year":"2025","unstructured":"Ren Y, Qin F, Shen L, Li L, Wu Q, Yi P. Triage of women with a positive HPV DNA test: Evaluating a DNA methylation panel for detecting cervical intraepithelial neoplasia grade 3 and cervical cancer in cervical cytology samples. BMC Cancer. 2025;25:1207. https:\/\/doi.org\/10.1186\/s12885-025-13996-8.","journal-title":"BMC Cancer"},{"key":"16209_CR26","doi-asserted-by":"publisher","first-page":"156116","DOI":"10.1016\/j.prp.2024.156116","volume":"273","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li X, Chen P, Yin Z, Zhu P, Zhang L, et al. ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval. Pathol Res Pract. 2025;273:156116. https:\/\/doi.org\/10.1016\/j.prp.2024.156116.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"16209_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12885-018-4492-2","volume":"18","author":"M Paz-Zulueta","year":"2018","unstructured":"Paz-Zulueta M, \u00c1lvarez-Paredes L, Rodr\u00edguez D\u00edaz JC, Par\u00e1s-Bravo P, Andrada Becerra ME, Rodr\u00edguez Ingelmo JM, et al. Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer. 2018;18(1):112. https:\/\/doi.org\/10.1186\/s12885-018-4492-2.","journal-title":"BMC Cancer"},{"key":"16209_CR28","doi-asserted-by":"publisher","first-page":"200247","DOI":"10.1016\/j.tvr.2022.200247","volume":"14","author":"AH L\u00f8vestad","year":"2022","unstructured":"L\u00f8vestad AH, Repesa A, Costanzi JM, Lagstr\u00f6m S, Christiansen IK, Rounge TB, et al. Differences in integration frequencies and APOBEC3 profiles of five high-risk HPV types adheres to phylogeny. Tumour Virus Res. 2022;14:200247. https:\/\/doi.org\/10.1016\/j.tvr.2022.200247.","journal-title":"Tumour Virus Res"},{"issue":"18","key":"16209_CR29","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.3390\/ijms26189214","volume":"26","author":"J Li","year":"2025","unstructured":"Li J, Li S. From viral infection to genome reshaping: The triggering role of HPV integration in cervical cancer. Int J Mol Sci. 2025;26(18):9214. https:\/\/doi.org\/10.3390\/ijms26189214.","journal-title":"Int J Mol Sci"},{"key":"16209_CR30","doi-asserted-by":"publisher","first-page":"32535","DOI":"10.1038\/s41598-025-92049-3","volume":"15","author":"L Solis-Ponce","year":"2025","unstructured":"Solis-Ponce L, Stosic M, Curic\u00f3 G, Espetia S, Sanchez-Grandez H, Hassan SS, et al. Genotype distribution and molecular characterization of HPV in the Peruvian Amazon: Insights into prevalence, lineage diversity, and viral integration. Sci Rep. 2025;15:32535. https:\/\/doi.org\/10.1038\/s41598-025-92049-3.","journal-title":"Sci Rep"},{"key":"16209_CR31","unstructured":"World Health Organization. Social determinants of health. Geneva: World Health Organization. Available from: https:\/\/www.who.int\/health-topics\/social-determinants-of-health. [Cited 1 Dec 2025]."},{"issue":"9","key":"16209_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.20892\/j.issn.2095-3941.2024.0209","volume":"22","author":"R Rezhake","year":"2025","unstructured":"Rezhake R, Abuduxikuer G, Abudurexiti G, Zhuo Q, Muhetaer K, Abulimiti T, et al. Evaluation of the multiple HPV-based screen and triage algorithms in real-world settings of rural China. Cancer Biol Med. 2025;22(9):1053\u201367. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0209.","journal-title":"Cancer Biol Med"},{"issue":"11","key":"16209_CR33","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00262-012-1241-5","volume":"61","author":"J Hu","year":"2012","unstructured":"Hu J, Li L, Pang L, Chen Y, Yang L, Liu C, et al. HLA-DRB11501 and HLA-DQB10301 alleles are positively associated with HPV16 infection-related kazakh esophageal squamous cell carcinoma in Xinjiang China. Cancer Immunol Immunother. 2012;61(11):2135\u201341. https:\/\/doi.org\/10.1007\/s00262-012-1241-5.","journal-title":"Cancer Immunol Immunother"},{"key":"16209_CR34","doi-asserted-by":"publisher","first-page":"31485","DOI":"10.1038\/srep31485","volume":"6","author":"J Huang","year":"2016","unstructured":"Huang J, Huang K, Xu R, Wang M, Liao Q, Xiong H, et al. The associations of HLA-a02:01 and DRB111:01 with hepatitis C virus spontaneous clearance are independent of IL28B in the Chinese population. Sci Rep. 2016;6:31485. https:\/\/doi.org\/10.1038\/srep31485.","journal-title":"Sci Rep"},{"issue":"8","key":"16209_CR35","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/ijc.25426","volume":"127","author":"LA Dahlstr\u00f6m","year":"2010","unstructured":"Dahlstr\u00f6m LA, Ylitalo N, Sundstr\u00f6m K, Palmgren J, Ploner A, Eloranta S, et al. Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer. 2010;127(8):1923\u201330. https:\/\/doi.org\/10.1002\/ijc.25426.","journal-title":"Int J Cancer"},{"issue":"20","key":"16209_CR36","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/jama.2023.21877","volume":"330","author":"RL Winer","year":"2023","unstructured":"Winer RL, Lin J, Anderson ML, Tiro JA, Green BB, Gao H, et al. Strategies to increase cervical cancer screening with mailed human papillomavirus self-sampling kits: A randomized clinical trial. JAMA. 2023;330(20):1971\u201381. https:\/\/doi.org\/10.1001\/jama.2023.21877.","journal-title":"JAMA"},{"issue":"4","key":"16209_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jncc.2022.11.002","volume":"2","author":"X Zhao","year":"2022","unstructured":"Zhao X, Hu S, Zhao S, Rezhake R, Huang L, Duan X, et al. Risk assessment of self-sampling HPV tests based on PCR, signal amplification to guide the appropriate screening intervals: A prospective study in China. J Natl Cancer Cent. 2022;2(4):298\u2013305. https:\/\/doi.org\/10.1016\/j.jncc.2022.11.002.","journal-title":"J Natl Cancer Cent"},{"issue":"43","key":"16209_CR38","doi-asserted-by":"publisher","first-page":"e2406367","DOI":"10.1002\/advs.202406367","volume":"11","author":"J Zhang","year":"2024","unstructured":"Zhang J, Dong Z, Xu L, Han X, Sheng Z, Chen W, et al. An injection molded SlipChip with self-sampling for integrated point-of-care testing of human papilloma virus. Adv Sci (Weinh). 2024;11(43):e2406367. https:\/\/doi.org\/10.1002\/advs.202406367.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"16209_CR39","first-page":"332","volume":"41","author":"LY Li","year":"2025","unstructured":"Cervical Cancer Committee of China Anti-Cancer Association, Li LY. Cervical cancer screening standards (2025 edition). Chin J Pract Gynecol Obstet. 2025;41(3):332\u20137.","journal-title":"Chin J Pract Gynecol Obstet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16209-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16209-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:10:22Z","timestamp":1784855422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16209-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16209"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16209-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8607078\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of People\u2019s Hospital of Xinjiang Uygur Autonomous Region (Approval No.: KY2022080502). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was waived from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"894"}}